Latest Health News

Tag: nebraska

  • Buffett defends Berkshire’s big Coke stake

    —

    by

    creative
    in

    Warren Buffett on Saturday vigorously defended Berkshire Hathaway Inc’s large, long-standing investment in Coca-Cola Co, rejecting critics who say the company’s sugary drinks harm people’s health. Speaking at Berkshire’s annual shareholder meeting in Omaha, Nebraska, Buffett said it seemed “spurious” to argue that calories from Coke alone were a significant factor in obesity levels. Hedge…

  • U.S. top court rejects suit against Colorado over marijuana law

    —

    by

    admin
    in

    The U.S. Supreme Court on Monday threw out a lawsuit filed by the states of Nebraska and Oklahoma against their neighbor Colorado over a law approved as a ballot initiative by Colorado voters in 2012 that allows the recreational use of marijuana. The court declined to hear the case filed by Nebraska and Oklahoma, which…

  • U.S. top court rejects suit against Colorado over marijuana law

    —

    by

    creative
    in

    The U.S. Supreme Court on Monday threw out a lawsuit filed by the states of Nebraska and Oklahoma against their neighbor Colorado over a law approved as a ballot initiative by Colorado voters in 2012 that allows the recreational use of marijuana. The court declined to hear the case filed by Nebraska and Oklahoma, which…

  • BioMarin drug fails to show inattention, mood benefit in study

    —

    by

    publisher
    in

    BioMarin Pharmaceutical Inc’s drug met a study’s main goal of reducing a toxic buildup of an amino acid in the blood of patients with a genetic disorder, but did not show enough benefit in related inattention and mood complications. BioMarin’s shares fell as much as 6 percent in early trading on Monday after the company…

  • Illicit drugs? How Brexit risks legal limbo for medicines

    —

    by

    elegant
    in

    By Ben Hirschler LONDON (Reuters) – A British vote to leave the European Union would threaten some prescription medicines with regulatory limbo, posing a legal headache for drugmakers, according to lawyers and industry officials. The highly regulated pharmaceutical sector has more at stake than most from a so-called Brexit, prompting top manufacturers GlaxoSmithKline and AstraZeneca…